Instrument Inactif

Autres langues Ultima Networks plc London S.E.

Actions

GB0005895098

Recherche biotechnologique et médicale

Cours en clôture London S.E. Autres places de cotation
- ^GBX	-

24/06	Tullow Oil procède à un remboursement partiel de ses obligations	AN
24/06	Les actions évoluent en ordre dispersé, sans « contagion » après la baisse à Wall Street	AN

Autres langues

24/06	Tullow Oil makes partial notes repayment
24/06	Thalia Therapeutics Plc agreed to acquire Sanmirna Therapeutics Inc from NLC Ventures Netherlands B.V., NLC Health Impact Fund, David Solomon and City Of Hope.
24/06	Stocks mixed but no "contagion" from US sell-off
24/06	Thalia Therapeutics to Buy Sanmirna Therapeutics; Conditionally Raises Funds
24/06	Thalia Therapeutics PLC Announces Acquisition and £2.75 Million Fundraise
23/06	Thalia Therapeutics eyes adding microRNA therapeutic asset
23/06	Thalia Therapeutics Plc Reports Earnings Results for the Full Year Ended December 31, 2025
09/06	EARNINGS AND TRADING: Asia Strategic Holdings revenue declines
20/04	Thalia Therapeutics plc Announces Change of Registered Address
15/04	WINNERS & LOSERS: Oracle Power shines; Ferrexpo output plunges
13/04	WINNERS & LOSERS: Energy stocks up; Wise gains on growth update
18/03	N4 Pharma Plc will Change its Ticker to THAT from N4P
18/03	N4 Pharma Plc will Change its Name to Thalia Therapeutics plc
17/03	N4 Pharma shareholders pass resolution to change co name to Thalia Therapeutics
17/03	N4 Pharma Shareholders Approve Name Change to Thalia Therapeutics
27/02	N4 Pharma proposes name change to Thalia Therapeutics
24/02	N4 Pharma to Rebrand as Thalia Therapeutics
24/02	N4 Pharma Names Zealand Pharma CEO to Same Role
24/02	N4 Pharma plc appoints David H Solomon as CEO
24/02	N4 Pharma plc Announces CEO Changes
24/02	Nigel Theobald Steps Down as Director of N4 Pharma Plc, Effective from 24 February 2026
17/12	EARNINGS AND TRADING: Tariffs weigh on Character Group annual earnings
25/09/25	EARNINGS AND TRADING: Comptoir loss narrows; Journeo profit down
25/09/25	N4 Pharma : Interim Results - 2025 (250925 N4 Pharma Interim Results RNS Final lnozqn)
25/09/25	N4 Pharma Plc Reports Earnings Results for the Half Year Ended June 30, 2025